On August 1, 2025, the Health Resources and Services Administration issued a new pilot initiative under the 340B Drug Pricing Program that may significantly reshape longstanding pricing and discount frameworks. The 340B Rebate Model Pilot Program will allow participating drug manufacturers to offer post-sale, rebates to eligible 340B Covered Entities for select drugs, rather than providing upfront discounts.
Applied Behavior Analysis therapy providers operating clinic-based environments in New York City and New York State have recently experienced increased scrutiny and enforcement actions from different regulatory authorities, including the New York State Office of Children and Family Services, and the New York City Department of Health and Mental Hygiene.
As part of Governor Kathy Hochul’s commitment “to transform the mental health care system (in New York) over the next several years,” the state has enacted new legislation and allotted $160 million dollars towards increasing the number of in-patient psychiatric beds in New York.
Health care providers and other entities are increasingly facing class action lawsuits over the use of tracking technologies on their websites—particularly pixels that transmit user data to platforms like Meta and Google. One such case recently settled for $6.75 million. These lawsuits often catch providers off guard, as they stem from routine, widely used website configurations.
OIG issued an unfavorable opinion (25-08) in which a medical device company proposed to pay a third-party vendor a yearly flat fee to access Vendor’s electronic billing portal.